Sherif Abdelaziz Ibrahim
Overview
Explore the profile of Sherif Abdelaziz Ibrahim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osama A, Anwar A, Ezzeldin S, Ahmed E, Mahgoub S, Ibrahim O, et al.
J Adv Res
. 2025 Jan;
PMID: 39870302
Introduction: Gut microbiota alterations have been implicated in Autism Spectrum Disorder (ASD), yet the mechanisms linking these changes to ASD pathophysiology remain unclear. Objectives: This study utilized a multi-omics approach...
2.
Wang Y, Esa S, Yu R, Ibrahim S, Li Y, Sheng Z, et al.
J Pharm Pharmacol
. 2025 Jan;
77(3):404-417.
PMID: 39847514
Objectives: Pancreatic cancer, a highly invasive and prognostically unfavorable malignant tumor, consistently exhibits resistance to conventional chemotherapy, leading to substantial side effects and diminished patient quality of life. This highlights...
3.
Abd El Rahiem R, Ibrahim S, Effat H, El-Houseini M, Osman R, Abdelraouf A, et al.
Asian Pac J Cancer Prev
. 2024 May;
25(5):1589-1598.
PMID: 38809630
Introduction: Diagnosis of the majority of hepatocellular carcinoma (HCC) patients occurs at intermediate to advanced stages, with a few curative therapeutic options being available. It is therefore strongly urgent to...
4.
Ismail Y, Zakaria A, Allam R, Gotte M, Ibrahim S, Hassan H
Pathol Res Pract
. 2023 Dec;
253:154994.
PMID: 38071886
Background: Metaplastic breast cancer (MpBC) is rare, aggressive, and mostly triple-negative (TN) subtype of BC. We aimed to investigate the potential prognostic significance of Syndecan-1 (SDC1/CD138) expression in this unique...
5.
Emad B, WalyEldeen A, Hassan H, Sharaky M, Abdelhamid I, Ibrahim S, et al.
BMC Cancer
. 2023 Nov;
23(1):1151.
PMID: 38012585
Background: Triple-negative breast cancer (TNBC) is a lethal mammary carcinoma subtype that affects females and is associated with a worse prognosis. Chemotherapy is the only conventional therapy available for patients...
6.
Farouk A, Fahmy S, Soliman A, Ibrahim S, Sadek S
BMC Biotechnol
. 2023 Aug;
23(1):28.
PMID: 37537554
Background: Coelomic fluid, a pharmacologically active compound in earthworms, exhibits a range of biological activities, including antioxidant, anti-inflammatory, and anticancer. However, the biological activities exerted by the coelomic fluid can...
7.
Wischmann F, Troschel F, Frankenberg M, Kemper B, Vijaya Kumar A, Sicking M, et al.
J Cancer Res Clin Oncol
. 2023 Apr;
149(11):8455-8465.
PMID: 37088795
Purpose: MicroRNA-218 (miR-218) is a key regulator of numerous processes relevant to tumor progression. In the present study, we aimed to characterize the relationship between miR-218 and the Epidermal Growth...
8.
Motta J, Hassan H, Ibrahim S
Cancers (Basel)
. 2023 Mar;
15(6).
PMID: 36980680
Syndecans (SDC1 to 4), a family of cell surface heparan sulfate proteoglycans, are frequently expressed in mammalian tissues. SDCs are aberrantly expressed either on tumor or stromal cells, influencing cancer...
9.
10.
Abdelfattah M, Mohamed A, Ibrahim S, Fahmy S
Sci Rep
. 2023 Feb;
13(1):2090.
PMID: 36746995
Allolobophora calignosa (Ac) is a folk medicine for millennia, as it possesses many biological activities. This study aimed to investigate the chemo-preventive activity of A.calignosa coelomic fluid (AcCF) and A.calignosa...